This study aims to compare changes in a specific type of white blood cell between patients who have had COVID. The comparison will be between patients who received treatment in an Intensive Care Unit (ICU) and those whose treatment was managed on a hospital ward. The aim is to understand the long-term complications seen in patients who required ICU treatments.
Participation: For this study, blood samples and data from 44 COVID-19 BioResource volunteers were provided.
Organisation: This study is organised by Dr Alasdair Jubb from the Department of Medicine, University of Cambridge
